SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-22-014625
Filing Date
2022-05-20
Accepted
2022-05-20 16:30:43
Documents
21
Period of Report
2022-05-20
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 56528
2 ex4-1.htm EX-4.1 118187
3 ex4-2.htm EX-4.2 124172
4 ex10-1.htm EX-10.1 284776
5 ex10-2.htm EX-10.2 172448
6 ex99-1.htm EX-99.1 17261
7 ex99-2.htm EX-99.2 15396
8 ex99-1_001.jpg GRAPHIC 3785
9 GRAPHIC ex99-2_001.jpg GRAPHIC 3785
  Complete submission text file 0001493152-22-014625.txt   1180848

Data Files

Seq Description Document Type Size
10 XBRL SCHEMA FILE bfri-20220520.xsd EX-101.SCH 3884
11 XBRL DEFINITION FILE bfri-20220520_def.xml EX-101.DEF 27476
12 XBRL LABEL FILE bfri-20220520_lab.xml EX-101.LAB 37921
13 XBRL PRESENTATION FILE bfri-20220520_pre.xml EX-101.PRE 26095
15 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 6081
Mailing Address 120 PRESIDENTIAL WAY, SUITE 330 WOBURN MA 01801
Business Address 120 PRESIDENTIAL WAY, SUITE 330 WOBURN MA 01801 781-245-1325
Biofrontera Inc. (Filer) CIK: 0001858685 (see all company filings)

IRS No.: 473765675 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40943 | Film No.: 22948045
SIC: 2834 Pharmaceutical Preparations